EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Molecular Classification and Characterization of Noninsulinoma: Ready for Prime Time in Clinical Practice?

Kaijian Zhang iD

International Journal of Surgical Pathology · 2025

DOI: 10.1177/10668969251327748 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Surgical Pathology, 2025. Verfasst von Kaijian Zhang. Beteiligte Einrichtung: Pathology Department, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Insulinoma, Biomarkers, Tumor, Neuroendocrine Tumors. Die Arbeit nennt 66 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic neuroendocrine tumors are a heterogeneous group of rare clinical tumors, which can be classified into functional pancreatic neuroendocrine tumor (insulinoma is the most common) and noninsulinoma. Insulinoma and noninsulinoma have different mutation profiles. In noninsulinoma, ATRX/DAXX mutation is associated with alternative lengthening of telomeres-positive phenotype and positively correlated with poor prognosis. Copy number variation is also a prognostic marker for a high risk of recurrence. Scholars have used epigenetics as well as a multiomics approach (combining epigenetics, metabolomics, proteomics, etc) to molecularly type noninsulinoma, and there are huge differences in molecular expression and patient prognosis between different groups. In this manuscript, we summarize the published studies that utilized genome, epigenome, transcriptome, and proteome data to classify noninsulinoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsInsulinomaBiomarkers, TumorNeuroendocrine TumorsHumansMutationPrognosisDNA Copy Number Variations

Stichwörter der Autor:innen

epigenomegenomenoninsulinomaprognosisproteometranscriptome

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Pathology Department, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.

ORCID-Profile: Kaijian Zhang

Zitieren

APA

Zhang, K. (2025). Molecular Classification and Characterization of Noninsulinoma: Ready for Prime Time in Clinical Practice?. International Journal of Surgical Pathology. https://doi.org/10.1177/10668969251327748

Vancouver

Zhang K. Molecular Classification and Characterization of Noninsulinoma: Ready for Prime Time in Clinical Practice?. International Journal of Surgical Pathology. 2025. doi:10.1177/10668969251327748

BibTeX
@article{Zhang2025,
  author = {Zhang, Kaijian},
  title = {Molecular Classification and Characterization of Noninsulinoma: Ready for Prime Time in Clinical Practice?},
  journal = {International Journal of Surgical Pathology},
  year = {2025},
  doi = {10.1177/10668969251327748}
}
Kostenlos starten →